FSTL1 knockdown promoted IL-6 expression, epithelial-to-mesenchymal transition (EMT), and TNFα-induced degradation of NF-κB inhibitor (IκBα) in ccRCC cells. The gene discussed is FSTL1; the disease is nonpapillary renal cell carcinoma.